LeukoScan |
Human |
sulesomab |
sulesomab |
EMEA/H/C/000111 |
Immunomedics GmbH |
1997/02/14
|
Withdrawn |
Twinrix Paediatric |
Human |
hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
hepatitis A virus (inactivated);hepatitis B surface antigen |
EMEA/H/C/000129 |
GlaxoSmithKline Biologicals S.A. |
1997/02/10
|
Authorised |
Hycamtin |
Human |
topotecan |
topotecan |
EMEA/H/C/000123 |
Sandoz Pharmaceuticals d.d. |
1996/11/12
|
Authorised |
Olansek |
Human |
olanzapine |
olanzapine |
EMEA/H/C/000114 |
Eli Lilly Co. Ltd. |
1996/10/07
|
Withdrawn |
Crixivan |
Human |
indinavir |
indinavir sulfate ethanolate |
EMEA/H/C/000128 |
Merck Sharp & Dohme B.V. |
1996/10/04
|
Withdrawn |
Indimacis 125 |
Human |
igovomab |
igovomab |
EMEA/H/C/000065 |
CIS bio international |
1996/10/04
|
Withdrawn |
CEA-Scan |
Human |
arcitumomab |
arcitumomab |
EMEA/H/C/000041 |
Immunomedics GmbH |
1996/10/04
|
Withdrawn |
Invirase |
Human |
saquinavir |
saquinavir |
EMEA/H/C/000113 |
Roche Registration GmbH |
1996/10/03
|
Withdrawn |
Zyprexa |
Human |
olanzapine |
olanzapine |
EMEA/H/C/000115 |
CHEPLAPHARM Registration GmbH |
1996/09/27
|
Authorised |
Twinrix Adult |
Human |
hepatitis A (inactivated) and hepatitis B (rDNA) (HAB) vaccine (adsorbed) |
hepatitis A virus (inactivated);hepatitis B surface antigen |
EMEA/H/C/000112 |
GlaxoSmithKline Biologicals S.A. |
1996/09/19
|
Authorised |
Tecnemab K1 |
Human |
anti-melanoma mab fragments |
anti-melanoma mab fragments |
EMEA/H/C/000068 |
Amersham Sorin.S.r.l. |
1996/09/05
|
Withdrawn |
Rapilysin |
Human |
reteplase |
reteplase |
EMEA/H/C/000105 |
Actavis Group PTC ehf |
1996/08/29
|
Authorised |
Ecokinase |
Human |
reteplase |
reteplase |
EMEA/H/C/000106 |
Roche Registration Ltd. |
1996/08/29
|
Withdrawn |
Norvir |
Human |
ritonavir |
ritonavir |
EMEA/H/C/000127 |
AbbVie Deutschland GmbH Co. KG |
1996/08/25
|
Authorised |
Epivir |
Human |
lamivudine |
lamivudine |
EMEA/H/C/000107 |
ViiV Healthcare BV |
1996/08/08
|
Authorised |
Tritanrix HepB |
Human |
diphtheria (D), tetanus (T), pertussis (whole cell) (Pw) and hepatitis B (rDNA) (HBV) vaccine (adsorbed) |
Diphtheria toxoid;hepatitis B surface antigen;Bordetella pertussis (inactivated);tetanus toxoid |
EMEA/H/C/000093 |
GlaxoSmithKline Biologicals S.A. |
1996/07/19
|
Lapsed |
Bondronat |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/000101 |
Atnahs Pharma Netherlands B.V. |
1996/06/25
|
Authorised |
Destara |
Human |
ibandronic acid |
ibandronic acid |
EMEA/H/C/000103 |
Roche Registration Ltd. |
1996/06/25
|
Withdrawn |
Caelyx pegylated liposomal |
Human |
doxorubicin |
doxorubicin hydrochloride |
EMEA/H/C/000089 |
Baxter Holding B.V. |
1996/06/20
|
Authorised |
Rilutek |
Human |
riluzole |
Riluzole |
EMEA/H/C/000109 |
Sanofi Winthrop Industrie |
1996/06/10
|
Authorised |